Mackenzie Financial »

Syndax Pharmaceuticals shares owned by Mackenzie Financial

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Mackenzie Financial from 13F filings

Historical chart of Mackenzie Financial investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Mackenzie Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.1M 280k 21.86

More positions owned by Mackenzie Financial

Royal Bank of Canada Common Stock (RY)
Toronto-Dominion Bank/The Common Stock (TD)
State Street Corp Etp (SPY)
NVIDIA Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Bank of Montreal Common Stock (BMO)
Alphabet Common Stock (GOOGL)
Canadian Pacific Kansas City L Common Stock (CP)
Microsoft Corp Common Stock (MSFT)
Agnico Eagle Mines Common Stock (AEM)
Canadian Imperial Bank of Comm Common Stock (CM)
Manulife Financial Corp Common Stock (MFC)
Enbridge Common Stock (ENB)
Canadian Natural Resources Common Stock (CNQ)
Amazon.com Common Stock (AMZN)

View all positions for Mackenzie Financial

Top funds holding Syndax Pharmaceuticals

BlackRock
Kynam Capital Management
Goldman Sachs Group
State Street Corporation
Bank of America Corporation
Vanguard Capital Management
Deerfield Management Company
Eversept Partners
Geode Capital Management
Hood River Capital Management
Kingdon Capital Management
Franklin Resources
Millennium Management
Vanguard Portfolio Management
UBS Group

View all funds holding Syndax Pharmaceuticals